Molecular Biomarkers for Predicting Treatment Response in Psoriatic Arthritis
Rheumatic Disease Clinics of North America · 2025-08 · 51 (3) · e1-e15
DOI: 10.1016/j.rdc.2026.02.012 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Rheumatic Disease Clinics of North America, 2025-08. Verfasst von Andre Lucas Ribeiro und 8 weiteren Autor:innen. Beteiligte Einrichtung: Hospital de Clínicas de Porto Alegre, 50 Prof. Duplan Street, Unit 609, Porto Alegre 90420-030, Brazil. Hauptthemen laut MEDLINE: Arthritis, Psoriatic, Biomarkers, Antirheumatic Agents. Die Arbeit nennt 69 Literaturangaben. Gefördert von: UCB, Teijin Pharma, GlaxoSmithKline Biologicals.
Abstract (Originalsprache)
Predicting treatment response is a key unmet need for people with psoriatic disease. In this article, the importance of personalized medicine is emphasized and molecular biomarker concepts are discussed. The literature related to biomarkers of treatment response in psoriatic disease is reviewed in detail. Finally, the limitations of current candidate biomarkers, emerging biomarkers, and future directions and challenges in biomarker research are highlighted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hospital de Clínicas de Porto Alegre, 50 Prof. Duplan Street, Unit 609, Porto Alegre 90420-030, Brazil.
- Division of Musculoskeletal and Dermatological Sciences, Centre for Genetics and Genomics Versus Arthritis, School of Biological Sciences, Faculty of Biology Medicine and Health, University of Manchester, Manchester Aca…
- Department of Protein Science, SciLifeLab, KTH Royal Institute of Technology, Solna 171 65, Sweden.
- Patient Research Partner (PRP), GRAPPA-EU, Norway.
- Patient Research Partner (PRP), EULAR, Netherlands.
- School of Infection and Immunity, University of Glasgow, 120 University Place, Glasgow G12 8TA, UK.
Förderung
- UCB
- Teijin Pharma
- GlaxoSmithKline Biologicals
Zitieren
APA
Ribeiro, A. L., Barton, A., Schwenk, J. M., Bertheussen, H., de Wit, M., Goodyear, C., Siebert, S., Pennington, S. R., & FitzGerald, O. (2025). Molecular Biomarkers for Predicting Treatment Response in Psoriatic Arthritis. Rheumatic Disease Clinics of North America, 51(3), e1-e15. https://doi.org/10.1016/j.rdc.2026.02.012
Vancouver
Ribeiro AL, Barton A, Schwenk JM, Bertheussen H, de Wit M, Goodyear C, et al. Molecular Biomarkers for Predicting Treatment Response in Psoriatic Arthritis. Rheumatic Disease Clinics of North America. 2025;51(3):e1-e15. doi:10.1016/j.rdc.2026.02.012
BibTeX
@article{Ribeiro2025,
author = {Ribeiro, Andre Lucas and Barton, Anne and Schwenk, Jochen M and Bertheussen, Heidi and de Wit, Maarten and Goodyear, Carl and Siebert, Stefan and Pennington, Stephen R and FitzGerald, Oliver},
title = {Molecular Biomarkers for Predicting Treatment Response in Psoriatic Arthritis},
journal = {Rheumatic Disease Clinics of North America},
year = {2025},
volume = {51},
number = {3},
pages = {e1--e15},
doi = {10.1016/j.rdc.2026.02.012}
}
EUVIMED